Global leaders in patient advocacy assembled during the 2024 World Conference on Lung Cancer to shed light on ongoing initiatives.
In a Q&A with ILCN, patient advocate Isaac Joseph discusses the importance of patient advocacy in resource-limited settings.
Palliative care expert Dr. Jennifer Temel talks about the role of digital health apps in supportive care interventions during an interview with ILCN.
The legacies patients like Ms. Greco leave serve to remind the thoracic oncology community why its work is vital.
Ms. Elkins, co-founder of the EGFR Resisters advocacy group, will be remembered for her warm and energetic approach to furthering lung cancer research efforts.
Runner and patient advocate Angus Pratt says running three times a week may be the antithesis of what most people expect from a lung cancer patient, but not only is it possible, it is beneficial.
Advocate Angus Pratt explores the issues patients face while researching their disease when inaccurate and out-of-date information is everywhere.
Patient research advocate Angus Pratt reflects on the past year of advocacy coverage in ILCN and how the movement has evolved in recent years.
In light of recent data from the study of osimertinib with or without chemotherapy, patient advocate Ivy Elkins said the results may sway some to add chemo to their first-line treatment plan. However, for others, the impact on quality of life will not be worth it.
LungCAN Co-Chair Dusty Donaldson says training program helped just two advocates reach more than 630 million people in 32 states and five countries.